Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Assistance Publique - Hôpitaux de Paris
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
San Raffaele University
National Cancer Institute (NCI)
Brigham and Women's Hospital
Massachusetts General Hospital
Radboud University Medical Center
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)
University of Vermont Medical Center
OHSU Knight Cancer Institute
UNICANCER
University of Nebraska
University Health Network, Toronto
Boston University
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
University of Alabama at Birmingham
Zealand University Hospital
University Health Network, Toronto
Massachusetts General Hospital
Fundacion Clinic per a la Recerca Biomédica
Tampere University Hospital
Centre Hospitalier Universitaire de Nīmes
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Johns Hopkins University
Ohio State University Comprehensive Cancer Center
Institute of Cancer Research, United Kingdom
Institute of Cancer Research, United Kingdom
University of British Columbia
Kaiser Permanente
University of Chicago
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
French Society of Digestive Endoscopy
Mayo Clinic
Erasmus Medical Center
Fox Chase Cancer Center
HealthPartners Institute
UNC Lineberger Comprehensive Cancer Center
Izmir Ataturk Training and Research Hospital
Imperial College London
WellSpan Health
University of Medicine and Pharmacy at Ho Chi Minh City